Pharmaceutical Giants Invest in Virginia Pharma Training
AstraZeneca, Eli Lilly, and Merck have committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.
According to a memorandum of understanding signed by the companies and state entities, the training center will support the development of a skilled workforce for the pharmaceutical industry.
The companies, each of which is planning to build manufacturing facilities in Virginia, have partnered with the state government, including the Virginia Innovation Partnership Corp.
- AstraZeneca, Eli Lilly, and Merck have invested a cumulative $120 million in the project.
- The training center will focus on advanced pharmaceutical manufacturing.
- The state government and Virginia Innovation Partnership Corp. are also involved in the initiative.
Author's summary: Pharma giants invest $120M in Virginia training center.
More News
- Why Malaysia's Gig Workers Bill entrenches workers' dependency, not protection - Aliran
- An Instant Classic, the 2025 World Series Was a Huge Win for MLB
- Berlin state executive massively expands police powers
- 'People need to eat': Salvation Army hosts 'emergency food drive' to keep up with 'unprecedented demand'
- Steve García demolishes a lifeless David Onama with a first-round finish at UFC Vegas 110